Table 2.
a. Demographic characteristics of participants allocated at weeks 2 and 10a | |||||
---|---|---|---|---|---|
1st allocation (week 2) | 2nd allocation (week 10) | ||||
SC | TCM | SC | TCM | ||
Number b | 40 | 39 | 43 | 42 | |
Age | Years [Mean (SD)] | 42.3 (13.5) |
42.9 (13.0) |
43.7 (12.4) |
43.6 (12.0) |
Percent | |||||
Gender | Female | 85.0 | 87.2 | 86.0 | 88.1 |
Ethnic Categories | Hispanic or Latino Not Hispanic or Latino Unknown (individuals not reporting ethnicity) |
10.0 85.0 5.0 |
10.3 84.6 5.2 |
11.6 88.4 0 |
11.9 83.3 4.8 |
Racial Categories | White Non-white Unknown or not reported |
82.5 5.0 12.5 |
84.6 7.7 7.7 |
86.0 7.0 7.0 |
83.3 4.8 11.9 |
Education | ≤High School Some College College graduate Post Graduate education |
12.5 37.5 25.0 25.0 |
7.7 38.5 28.2 25.6 |
14.0 23.8 28.6 33.3 |
21.3 31.0 19.1 28.6 |
Marital Status | Married/ partnered Divorced/ Widowed/ Separated Never married/ partnered Not known |
37.5 27.5 35.0 0 |
59.0 10.2 30.8 0 |
46.5 30.2 23.3 0 |
54.8 21.4 23.8 0 |
Income ($) | No response <25K 25–50K 50–100K >100K |
5.0 32.5 22.5 27.5 12.5 |
2.6 30.8 35.9 25.6 5.1 |
11.6 23.3 27.9 25.6 11.6 |
4.8 33.3 31.0 21.4 9.5 |
TCM differentiations (most salient) |
Liver Qi Constraint Qi & Blood Stagnation Other c |
47.5 37.5 15.0 |
53.8 38.5 7.7 |
34.9 51.2 13.9 |
47.6 38.1 14.3 |
b Baseline Pain Characteristics for participants allocated at weeks 2 and 10 | |||||
---|---|---|---|---|---|
1st allocation (week 2) | 2nd allocation (week 10) | ||||
SC | TCM | SC | TCM | ||
Number | 40 | 39 | 43 | 42 | |
Variable | Mean (SD) | ||||
Worst facial pain [0–10] | 8.1(1.4) | 8.1(1.2) | 7.5(1.5) | 7.6(1.5) | |
Average facial pain [0–10] | 6.0(1.6) | 6.5(1.8) | 5.8(1.7) | 5.6(2.2) | |
Facial pain today [0–10] | 5.0(2.0) | 5.3(2.2) | 4.5(2.2) | 4.5(2.3) | |
Characteristic facial pain [0–10](mean of 3 above) | 6.4(1.4) | 6.6(1.4) | 5.9(1.5) | 5.8(2.0) | |
Days of facial paina | 4.9(1.4) | 4.8(1.3) | 4.7(1.4) | 4.6(1.6) | |
Amt. interferes with daily activities [0–10] | 4.3(2.3) | 3.8(2.6) | 3.5(2.2) | 3.8(2.7) | |
Amt. interferes with social activities [0–10] | 3.8(2.5) | 3.3(2.8) | 3.0(2.1) | 3.3(2.7) | |
Amt. interferes with ability to work [0–10] | 3.8(2.4) | 3.8(2.8) | 3.0(2.3) | 2.9(2.7) | |
Depression [1–4] | 2.0 (0.8) | 1.8 (0.6) | 1.7 (0.6) | 1.8 (0.8) | |
Sleep [1–4] | 2.8 (0.8) | 2.5 (0.8) | 2.7 (0.8) | 2.6 (0.8) | |
N of medications | 2.2 (1.5) | 1.8 (1.5) | 1.8 (1.4) | 1.9 (1.6) | |
AIOS [0–10] | 5.5 (2.1) | 5.6 (2.0) | 5.6 (1.9) | 5.9 (1.9) | |
Percent | |||||
Duration of pain | <1 year 1–10 years >10 years |
10.0 55.0 35.0 |
10.3 43.6 46.1 |
7.0 41.8 51.2 |
4.8 59.5 35.7 |
Visited a practitioner for pain treatment |
No Yes |
5.3 94.7 |
18.4 81.6 |
16.3 85.7 |
4.9 95.1 |
Nature of facial pain | Continuous | 47.5 | 41.0 | 44.2 | 43.9 |
Intermittent | 52.5 | 58.9 | 55.8 | 56.1 | |
Graded Chronic Pain score | 0–2 3–4 |
30 70 |
35.9 64.1 |
37.2 62.8 |
42.8 57.1 |
TMD Diagnostic Groups (RDC-TMD Axis I) |
Group 1a 1b |
53 41 |
39 42 |
61 25 |
46 41 |
Any Group 2 | 20 | 15 | 33 | 21 | |
Group 3a 3b–c |
63 5 |
67 0 |
47 5 |
52 2 |
|
Group 1 + 3a | 63 | 62 | 44 | 48 |
None of the between-group differences within allocation periods are significant at p<.05.
Note that per design some of the same people are represented in the baselines for SC in period one, and SC and TCM in period 2.
Full details of other baseline differentiations are found in [39].
1 = 0–3d, 2 = 4–7d, 3 = 8–14d, 4 = 15–21d, 5 = 22–27d, 6 = every day (out of the past month)